On August 26, SolarEdge rose 8.2% in regular trading, trading at $32.56/share, with turnover of $40.76 million. The rally was driven by UBS upgrading the stock from Neutral to Buy while raising its price target from $36 to $42.

UBS's upgraded target implies approximately 30% upside from current levels, signaling confidence in the company's medium-term recovery trajectory. This marks a notable shift for the investment bank, which had previously maintained a Neutral stance even after raising its target to $41 from $36 in early May. The current average analyst rating tracked by FactSet remains at Hold with a mean price target of $35.11, suggesting UBS holds a more constructive view than consensus.

The upgrade comes approximately three weeks after SolarEdge reported Q2 results on August 5, where revenue of $346.2 million beat estimates but Q3 guidance of $310-$340 million fell significantly short of the $368.1 million consensus, triggering a 27% single-day decline. The stock has been recovering from those post-earnings lows as the market reassesses the company's longer-term outlook.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)